Oncology Small Molecule Drugs Market to Reap Excessive Revenues by 2019 to 2029
The market for oncology small molecule drugs is envisaged to register ~6% CAGR through 2029, primarily driven by rapid technological advancement in healthcare sector that continues to pave way for new and improved product development.
View full press release